Kevin J. Esval, Advisory Board Member

Kevin J. Esval has served as Executive Managing Director of VelocityHealth Securities, Inc. a FINRA/SIPC licensed investment banking firm, since founding the company in 2000. Mr. Esval has extensive experience in debt and equity raises, mergers and acquisitions, strategic advisory assignments, and product licensing’s in all health care sectors including generic pharmaceuticals, specialty pharmaceuticals, medical devices and biotechnology. Previously, Mr. Esval served as a divisional SVP and COO for UnitedHealth Group (NYSE: UNH), one of the largest health care services companies in the world with annual revenues exceeding $75 billion. As one of the original startup executives of his division, Mr. Esval was instrumental in taking it from $0 to $400 million as of his departure. His career in health care began with a venture-backed startup Complete Health Services, Inc. This firm was one of Inc. Magazine’s “Fastest Growing Private Companies” in 1994. During this period, Mr. Esval was this company’s top sales executive and managed the startup of two new divisions. Additionally, Mr. Esval spent 5 years in sales, financial analysis, and trading roles at several financial derivatives companies, including Chicago based Rosenthal-Collins Group and R. J. O’Brien. While at these companies his roles included working on the floor of the Chicago Board of Trade (CBOT) and the Chicago Mercantile Exchange (CME). Mr. Esval has served as a director of numerous companies and currently serves as a Director of several pharmaceutical companies. Mr. Esval received his BA degree from Furman University. Additionally, he studied internationally in Lausanne, Switzerland and is a dual citizen of the USA & the EU. Mr. Esval also holds Series 7, 24 and 63 securities licenses.

 

<< Back to Our Team Main Advisory Board Members
Dr. Ian Clements
Kevin J. Esval
Paul Martin

 

 

 

 

80 Eighth Avenue, Suite 1107 New York, NY 10011 | T: (212) 242 – 7777 | F: (212) 242 – 7778 | info @shorehamgroupllc.com